COMP <GO>
ELAN vs UNH // ALTMAN Z-SCORE & DEBT/EQUITY
Elanco Animal Health Incorporated (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: ELAN 1
— UNH 12
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: UNH
LAST: $23.06 (-0.77%) • MKT CAP: $11.61B
balance-sheet
1.24
LAST: $406.97 (-0.96%) • MKT CAP: $364.66B
balance-sheet
3.12
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ELAN VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ELAN | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 55.00% | 88.57% | -33.57 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -2.50% | 11.47% | -13.97 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 16.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 2.45% | 6.48% | -4.03 | UNH | /fcf-yield <GO> |
| Operating Margin | -6.00% | 4.82% | -10.82 | UNH | /operating-margins <GO> |
| Net Profit Margin | -4.90% | 3.14% | -8.04 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | 6.20% | 6.46% | -0.26 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 1.24 | 3.12 | -1.88 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.80% | 6.74% | +0.06 | UNH | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.5 | 56.0 | -3.59 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.96 | 0.33 | +0.63 | ELAN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.0x | 17.1x | +2.91 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $11.61B | $364.66B | -$353.05B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ELAN REV | UNH REV | ELAN GROSS % | UNH GROSS % | ELAN FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.71B | $447.57B | 55.0% | 88.7% | $284.0M | $16.07B |
| FY 2024 | $4.44B | $400.28B | 54.9% | 88.3% | $394.0M | $20.70B |
| FY 2023 | $4.42B | $371.62B | 44.0% | 89.6% | $72.2M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ELAN // BETA 0.96
UNH // BETA 0.33